Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FMATG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,566
Award facts
- Contract value 100% obligated
- $5,565.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,565.94 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on October 23, 2025, with completion targeted for October 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center for federal medical procurement.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for military and federal healthcare systems through its DLA prime vendor contract. This delivery order falls within the company's comprehensive pharmaceutical supply portfolio, which includes specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Dupixent is a biologic medication indicated for conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, reflecting the breadth of therapeutic support provided through federal pharmaceutical procurement channels.
Quick answers
Who was awarded contract SPE2DB26FMATG?
SPE2DB26FMATG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FMATG worth?
The government has obligated $5,566 on SPE2DB26FMATG.
Is contract SPE2DB26FMATG an order under another contract?
Yes. SPE2DB26FMATG is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMATG competed?
The extent of competition for SPE2DB26FMATG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award